BACKGROUND	IncobotulinumtoxinA has been approved for treatment of glabellar frown lines ( GFL ) in the United States , all major European markets , South Korea , and Argentina and in Russia and Mexico for the treatment of mimic wrinkles and hyperkinetic facial lines , respectively .\